Merus’ zenocutuzumab is nearing FDA approval, and petosemtamab shows promise. Learn why MRUS stock could rise as the company ...

Total rainfall of 19.69 inches in the mountains near Lake Jocassee northwest of Greenville from Sept. 26-29th. That’s the ...

Viking Therapeutics (VKTX) announced that results from the company’s Phase 2b clinical trial of VK2809, the company’s novel liver-selective ...

Big data technology is revolutionizing industries by providing valuable insights that drive better decision-making and ...

Explore how Gujarat's government plans to harness artificial intelligence, deep-tech, and data analytics to enhance public ...

The presentations will highlight data from Opna’s lead clinical programs, OPN-2853 and OPN-6602. The data presentations will include an interim analysis of the ongoing Phase 1 study of OPN-2853 ...

(NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will have three data presentations at the upcoming ...

U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to serious mental health problems for some patients, according to a scientific ...